A dimensional approach to the autism spectrum

CNS Spectrums

Volumn 3, Issue 3, 1998, Pages 22-39

  Hollander, Eric ^a,d   Cartwright, Charles ^a,c   Wong, Cheryl M ^a,b   Decaria, Concerta M ^b   Delgiudice Asch, Gina ^a   Buchsbaum, Monte S ^a   Aronowitz, Bonnie R ^a  

^a Mt Sinai Sch of Med in Aeir York   (United States)

^b Department of Psychiatry ^*

^c Dept Psychiat Director of the PET

^d Ml Sinai Sch of Med in Aeir York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; OXYTOCIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AUTISM; CINGULATE GYRUS; CLINICAL TRIAL; COMMUNICATION DISORDER; COMPULSION; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOPATHOLOGY; NEUROBIOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL DISABILITY;

EID: 0032455143     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900005678     Document Type: Review

References (43)

1. American Psychiatrie Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Rutter M. Language, cognition and autism. In: Katzman R, ed. Congenital and Acquired Cognitive Disorders. New York, NY: Raven Press; 1979:247-267.
3. Volkmar FR, Nelson DS. Seizure disorders in autism. J AmAcad Child Adolesc Psychiatry. 1990;29:127-129.
4. Bailey A, Le Couleur A, Gottesman I, et al. Autism as a strongly genetic disorder evidence from a British twin study. Psychol Med. 1995;25:63-78.
5. Le Couleur A, Bailey A, Goode S, et al. A broader phenotype of autism: the clinical spectrum in twins. }Child Psychol Psychiatry. 19%;37:785-801.
6. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological and neurobiological perspectives. J Child Psychol Psychiatry. 1996;37:89-126.
7. Bolton P, Macdonald H, Pickles A, et al. A case-control family history study of autism. J Child Psychol Psychiatry. 1994;35:877-900.
8. Piven J, Palmer P, Jacobi D, et al. Broader autism phenotype: evidence from a family history study of multipleincidence autism families. Am ] Psychiatry. 1997;154:185-190.
9. Wolf S, Chick J. Schizoid personality in childhood: a controlled follow-up study. PsychoLMed. 1980;10:85-100.
10. Smalley SL, McCracken J, Tanguay P. Autism, affective disorders and social phobia. Am J Med Genet. 1995;60:19-26.
11. McDougle CJ, Kresch LE, Goodman WK, et al. A casecontrolled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995;152:772-777.
12. Schain RJ, Freedman DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. ; Pedialr. 1961;58:315-320.
13. Cook EK, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr. 1996;8:348-354.
14. Piven J, Tsai G, Nehme E, et al. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21:51-59.
15. Cook EH, Charak DA, Arida J, et al. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res. 1994;52:25-33.
16. McDougle CJ, Naylor ST, Cohen DJ, et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch ten Psychiatry. 1996;53:993-1000.
17. Hollander E, DeCaria CM, Nitescu A, et al. Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to oral m-CPP and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry. 1992;49:21-28.
18. Hollander E, Prohovnik I, Stein DJ. Obsessions and cerebral blood flow during pharmacological challenge with m-CPP. J Neuropsychiatry Clin Neurosci. 1995;7:485490.
19. McBride PA, Anderson GM, Hertzig ME, et al. Serotonergic responsivity in male young adults with autistic disorder: results of a pilot study. Arch Gen Psychiatry. 1989;14:213-221.
20. Gordon CT, State RC, Nelson JE, et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry. 1993;50:441-447.
21. Sanchez LE, Campbell M, Small AM, et al. A pilot study of clomipramine in young autistic children. / Am Acad Child Adolesc Psychiatry. 1996;35:537-544.
22. Brasic JR, Barnett JY, Kaplan D, et al. Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology. 1994;44:1309-1312.
23. Cook EH, Rowlett R, Jaselskis C, et al. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. / Am Acad Child Adolesc Psychiatry. 1992;31:739-745.
24. McDougle CJ, Naylor ST, Cohen DJ, et al. A doubleblind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53:1001-1008.
25. Potenza MN, McDougle CJ. The role of serotonin in autism-spectrum disorders. CNS Spectrums. 1997;2:2542.
26. Devinsky 0, Morell MJ, Vogt BA. Contributions of the anterior cingulate cortex to behavior. Brain. 1995;118:279-306.
27. Degos JD, da Fonseca N, Gray F, et al. Severe frontal syndrome associated with infarcts of the left anterior cingulate gyrus and the head of the right caudate nucleus: a clinicopathological case. Brain. 1993;! 16:1541-1548.
28. George MS, Ketter TA, Gill DS, et al. Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. J Neuropsychiatry Clin Neurosd. 1993;5:384-394.
29. Swedo SE, Shapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46:518-523.
30. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595-606.
31. Buchsbaum MS, Wu J, Siegel BV, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997;41:15-22.
32. Haznedar MM, Buchsbaum MS, Metzger M, et al. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry. 1997;154;10471050.
33. SS.Zabriskie JB, Lavernchy RC, Williams JR, et al. Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 1985;28:1047-1051.
34. Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pédiatrie autoimmune neuropsychiatrie disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110-112.
35. Murphy TK, Goodman WK, Fudge MW, et al. B lymphocyte antigen D8/17: a peripheral marker for childhoodonset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 1997;154:402-407.
36. Hollander E, DelGiudice-Asch G, Simon L, et al. Repetitive behaviors and D8/17 positivity. Am J Psychiatry. 1997;154:1630. Letter.
37. Insel TR. A neurobiological basis of social attachment. Am ] Psychiatry. 1997;154:726-735.
38. Tribollet E, Charpak S, Schmidt A, et al. Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology./AWosci. 1989;9:1764-1773.
39. Pansksepp J. Commentary on the possible role of oxytocin in autism. J Autism Dev Disord. 1993;23:567-569.
40. Modahl C, Fein D, Waterhouse L. Does oxytocin deficiency mediate social deficits in autism? J Autism Dev Disord. 1992;22:449-451.
41. Leckman JF, Goodman WK, North WG, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;5:782-792.
42. Waterhouse L, Fein D, Modahl C. Neurofunctional mechanisms in autism. Psychol Rev. 1996;103:457-489.
43. Fein D, Allen D, Dünn M, et al. Pitocin induction and autism. Am J Psychiatry. 1997;154:438-439. Letter.